Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Inai

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1985
[Complement component deficiency]Y Akagaki, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1976
Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharidesK Nagaki, S Inai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 29, 1979
[Analysis of complement]S Inai, R Yasuda
Molecular Immunology|November 1, 1983
Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibodyY Akagaki, S Inai
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1974
Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8H Kitamura, S Inai
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1978
[Clotting-fibrinolytic system and complements (author's transl)]K Nagaki, S Inai
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1990
[Clinical significance of C6, C7, C9 and C1-INH analysis]Y Akagaki, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1976
Necessity of the divalent cation in the reaction between EAC1-8hu and C9gpH Kitamura, M Matsumoto, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1974
The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponentsK Nagaki, K Iida, S Inai
Journal of Clinical & Laboratory Immunology|July 1, 1981
Further studies on C9 deficiencyH Kitamura, K Nagaki, S Inai
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1985
[Complement component deficiency]Y Akagaki, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1976
Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharidesK Nagaki, S Inai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 29, 1979
[Analysis of complement]S Inai, R Yasuda
Molecular Immunology|November 1, 1983
Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibodyY Akagaki, S Inai
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1974
Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8H Kitamura, S Inai
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1978
[Clotting-fibrinolytic system and complements (author's transl)]K Nagaki, S Inai
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1990
[Clinical significance of C6, C7, C9 and C1-INH analysis]Y Akagaki, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1976
Necessity of the divalent cation in the reaction between EAC1-8hu and C9gpH Kitamura, M Matsumoto, S Inai
International Archives of Allergy and Applied Immunology|January 1, 1974
The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponentsK Nagaki, K Iida, S Inai
Journal of Clinical & Laboratory Immunology|July 1, 1981
Further studies on C9 deficiencyH Kitamura, K Nagaki, S Inai
Pageof 7